AI may Offer a Better Way to ID Drug-Resistant Superbugs

Biomedical engineers at Duke University have shown that different strains of the same bacterial pathogen can be distinguished by a machine learning analysis of their growth dynamics alone, which can then also accurately predict other traits such as resistance to antibiotics. The demonstration could point to methods for identifying diseases and predicting their behaviors that are faster, simpler, less expensive and more accurate than current standard techniques.

The results appear online on August 3 in the Proceedings of the National Academy of Sciences.

For most of the history of microbiology, bacteria identification has relied on growing cultures and analyzing the physical traits and behaviors of the resulting bacterial colony. It wasn't until recently that scientists could simply run a genetic test.

Genetic sequencing, however, isn't universally available and can often take a long time. And even with the ability to sequence entire genomes, it can be difficult to tie specific genetic variations to different behaviors in the real world.

For example, even though researchers know the genetic mutations that help shield/protect bacteria from beta-lactam antibiotics--the most commonly used antibiotic in the world--sometimes the DNA isn't the whole story. While a single resistant bacteria usually can't survive a dose of antibiotics on its own, large populations often can.

Lingchong You, professor of biomedical engineering at Duke, and his graduate student, Carolyn Zhang, wondered if a new twist on older methods might work better. Maybe they could amplify one specific physical characteristic and use it to not only identify the pathogen, but to make an educated guess about other traits such as antibiotic resistance.

"We thought that the slight variance in the genes between strains of bacteria might have a subtle effect on their metabolism," You said. "But because bacterial growth is exponential, that subtle effect could be amplified enough for us to take advantage of it. To me, that notion is somewhat intuitive, but I was surprised at how well it actually worked."

How quickly a bacterial culture grows in a laboratory depends on the richness of the media it is growing in and its chemical environment. But as the population grows, the culture consumes nutrients and produces chemical byproducts. Even if different strains start with the exact same environmental conditions, subtle differences in how they grow and influence their surroundings accumulate over time.

In the study, You and Zhang took more than 200 strains of bacterial pathogens, most of which were variations of E. coli, put them into identical growth environments, and carefully measured their population density as it increased. Because of their slight genetic differences, the cultures grew in fits and starts, each possessing a unique temporal fluctuation pattern. The researchers then fed the growth dynamics data into a machine learning program, which taught itself to identify and match the growth profiles to the different strains.

To their surprise, it worked really well.

"Using growth data from only one initial condition, the model was able to identify a particular strain with more than 92 percent accuracy," You said. "And when we used four different starting environments instead of one, that accuracy rose to about 98 percent."

Taking this idea one step further, You and Zhang then looked to see if they could use growth dynamic profiles to predict another phenotype - antibiotic resistance.

The researchers once again loaded a machine learning program with the growth dynamic profiles from all but one of the various strains, along with data about their resilience to four different antibiotics. They then tested to see if the resulting model could predict the final strain's antibiotic resistances from its growth profile. To bulk up their dataset, they repeated this process for all of the other strains.

The results showed that the growth dynamic profile alone could successfully predict a strain's resistance to antibiotics 60 to 75 percent of the time.

"This is actually on par or better than some of the current techniques in the literature, including many that use genetic sequencing data," said You. "And this was just a proof of principle. We believe that with higher-resolution data of the growth dynamics, we could do an even better job in the long term."

The researchers also looked to see if the strains exhibiting similar growth curves also had similar genetic profiles. As it turns out, the two are completely uncorrelated, demonstrating once again how difficult it can be to map cellular traits and behaviors to specific stretches of DNA.

Moving forward, You plans to optimize the growth curve procedure to reduce the time it takes to identify a strain from 2 to 3 days to perhaps 12 hours. He's also planning on using high-definition cameras to see if mapping how bacterial colonies grow in space in a Petri dish can help make the process even more accurate.

Carolyn Zhang, Wenchen Song, Helena R Ma, Xiao Peng, Deverick J Anderson, Vance G Fowler Jr, Joshua T Thaden, Minfeng Xiao, Lingchong You.
Temporal encoding of bacterial identity and traits in growth dynamics.
PNAS, 2020, doi: 10.1073/pnas.2008807117.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...